The antimicrobial peptide pardaxin exerts potent anti-tumor activity against canine perianal gland adenoma

Oncotarget

Volumn 6, Issue 4, 2015, Pages 2290-2301

  Pan, Chieh Yu ^a   Lin, Chao Nan ^b   Chiou, Ming Tang ^b   Yu, Chao Yuan ^c   Chen, Jyh Yih ^d   Chien, Chi Hsien ^b  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c Genomics BioSci and Tech Co Ltd   (Taiwan)

^d INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

Antimicrobial peptide; Cancer treatment; Canine; Intratumoral treatment; Pardaxin; Perianal gland adenoma

Indexed keywords

PARDAXIN; ANTIMICROBIAL CATIONIC PEPTIDE; ANTINEOPLASTIC AGENT; CHOLESTEROL; FISH VENOM; NEUROTOXIN; PLASMA PROTEIN; TRIACYLGLYCEROL;

ADENOMA; ANUS TUMOR; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; DOG; DRUG EFFICACY; FEMALE; FIBROSARCOMA; GENE EXPRESSION; HISTIOCYTOMA; MALE; MASTOCYTOMA; MAXIMUM TOLERATED DOSE; NONHUMAN; PERIANAL GLAND; PERIANAL GLAND ADENOMA; SARCOMA; SQUAMOUS CELL CARCINOMA; TUMOR NECROSIS; TUMOR REGRESSION; AMINO ACID SEQUENCE; ANAL GLAND NEOPLASMS; ANIMAL; BLOOD; DRUG EFFECTS; HUMAN; LEUKOCYTE COUNT; MOLECULAR GENETICS; PATHOLOGY; PROCEDURES; SYNTHESIS; TIME FACTOR; TREATMENT OUTCOME; TUMOR VOLUME; VETERINARY MEDICINE;

ADENOMA; AMINO ACID SEQUENCE; ANAL GLAND NEOPLASMS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CHOLESTEROL; DOGS; FISH VENOMS; HUMANS; LEUKOCYTE COUNT; MOLECULAR SEQUENCE DATA; NEUROTOXINS; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; TUMOR BURDEN; VETERINARY MEDICINE;

EID: 84922981828     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2959     Document Type: Article

References (42)

1. Rangarajan A and Weinberg RA. Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer. 2003;3(12):952-959.
2. Pinho SS, Carvalho S, Cabral J, Reis CA and Gärtner F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res. 2012;159(3):165-172.
3. Vail DM and MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 2000;18(8):781-792.
4. Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, Barber L, Breen M, Kitchell B, McNeil E, Modiano JF, Niemi S, Comstock KE, Ostrander E, Westmoreland S and Withrow S. The dog as a cancer model. Nat Biotechnol. 2006;24(9):1065-1066.
5. Knapp DW, Ramos-Vara JA, Moore GE, Dhawan D, Bonney PL and Young KE. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J. 2014;55(1):100-118.
6. Rodriguez CO Jr. Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks? Adv Exp Med Biol. 2014;804:237-256.
7. Gavazza A, Lubas G, Fridman A, Peruzzi D, Impellizeri JA, Luberto L, Marra E, Roscilli G, Ciliberto G and Aurisicchio L. Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma. Hum Gene Ther. 2013;24(8):728-738.
8. Chevalier S, Cury FL, Scarlata E, El-Zayat E, Hamel L, Rocha J, Zouanat FZ, Moussa S, Scherz A, Elhilali M and Anidjar M. Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model. J Urol. 2013;190(5):1946-1953.
9. Bentley RT, Mund JA, Pollok KE, Childress MO and Case J. Peripheral blood biomarkers of solid tumor angiogenesis in dogs: a polychromatic flow cytometry pilot study. Vet J. 2013;196(2):236-240.
10. Wu SP, Huang TC, Lin CC, Hui CF, Lin CH and Chen JY. Pardaxin, a fish antimicrobial peptide, exhibits anti-tumor activity toward murine fibrosarcoma in vitro and in vivo. Mar Drugs. 2012;10(8):1852-1872.
11. Lin MC, Lin SB, Chen JC, Hui CF and Chen JY. Shrimp anti-lipopolysaccharide factor peptide enhances the anti-tumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice. Peptides. 2010;31(6):1019-1025.
12. Szczepanski C, Tenstad O, Baumann A, Martinez A, Myklebust R, Bjerkvig R and Prestegarden L. Identification of a novel lytic peptide for the treatment of solid tumours. Genes Cancer. 2014;5(5-6):186-200.
13. Shevtsov MA, Kim AV, Samochernych KA, Romanova IV, Margulis BA, Guzhova IV, Yakovenko IV, Ischenko AM and Khachatryan WA. Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children. Onco Targets Ther. 2014;7:1071-1081.
14. Ren S, Li C, Dai Y, Li N, Wang X, Tian F, Zhou S, Qiu Z, Lu Y, Zhao D, Chen X and Chen D. Comparison of pharmacokinetics, tissue distribution and pharmacodynamics of liposomal and free doxorubicin in tumour-bearing mice following intratumoral injection. J Pharm Pharmacol. 2014;66(9):1231-1239.
15. Hilchie AL, Conrad DM, Coombs MR, Zemlak T, Doucette CD, Liwski RS and Hoskin DW. Pleurocidin-family cationic antimicrobial peptides mediate lysis of multiple myeloma cells and impair the growth of multiple myeloma xenografts. Leuk Lymphoma. 2013;54(10):2255-2262.
16. Hilchie AL, Doucette CD, Pinto DM, Patrzykat A, Douglas S and Hoskin DW. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts. Breast Cancer Res. 2011;13(5):R102.
17. Chen Y, Xu X, Hong S, Chen J, Liu N, Underhill CB, Creswell K and Zhang L. RGD-Tachyplesin inhibits tumor growth. Cancer Res. 2001;61(6):2434-2438.
18. Giuliani A, Pirri G, Bozzi A, Di Giulio A, Aschi M and Rinaldi AC. Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell Mol Life Sci. 2008;65(16):2450-2460.
19. Cerón JM, Contreras-Moreno J, Puertollano E, de Cienfuegos Gá, Puertollano MA and de Pablo MA. The antimicrobial peptide cecropin A induces caspase-independent cell death in human promyelocytic leukemia cells. Peptides. 2010;31(8):1494-1503.
20. Huang TC, Lee JF and Chen JY. Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ROS-mediated apoptosis in HT-1080 cells. Mar Drugs. 2011;9(10):1995-2009.
21. Huang HN, Pan CY, Chan YL, Chen JY and Wu CJ. Use of the antimicrobial peptide pardaxin (GE33) to protect against methicillin-resistant Staphylococcus aureus infection in mice with skin injuries. Antimicrob Agents Chemother. 2014;58(3):1538-1545.
22. Pal R, Barenholz Y and Wagner RR. Transcription of vesicular stomatitis virus activated by pardaxin, a fish toxin that permeabilizes the virion membrane. J Virol. 1981;39(2):641-645.
23. Saberwal G and Nagaraj R. A synthetic peptide corresponding to the hydrophobic amino terminal region of pardaxin can perturb model membranes of phosphatidyl choline and serine. Biochim Biophys Acta. 1989;984(3):360-364.
24. Nikodijevic B, Nikodijevic D and Lazarovici P. Pardaxin-stimulated calcium uptake in PC12 cells is blocked by cadmium and is not mediated by L-type calcium channels. J Basic Clin Physiol Pharmacol. 1992;3(4):359-370.
25. Shai Y and Oren Z. Diastereoisomers of cytolysins, a novel class of potent antibacterial peptides. J Biol Chem. 1996;271(13):7305-7308.
26. Hsu JC, Lin LC, Tzen JT and Chen JY. Pardaxin-induced apoptosis enhances anti-tumor activity in HeLa cells. Peptides. 2011;32(6):1110-1116.
27. Huang TC and Chen JY. Proteomic analysis reveals that pardaxin triggers apoptotic signaling pathways in human cervical carcinoma HeLa cells: cross talk among the UPR, c-Jun and ROS. Carcinogenesis. 2013;34(8):1833-1842.
28. Ting CH, Huang HN, Huang TC, Wu CJ and Chen JY. The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS. Biomaterials. 2014;35(11):3627-3640.
29. Hoskin DW and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta. 2008;1778(2):357-375.
30. Schweizer F. Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol. 2009;625(1-3):190-194.
31. Gaspar D, Veiga AS and Castanho MA. From antimicrobial to anticancer peptides. A review. Front Microbiol. 2013;4:294.
32. Chen C, Hu J, Zeng P, Pan F, Yaseen M, Xu H and Lu JR. Molecular mechanisms of anticancer action and cell selectivity of short a-helical peptides. Biomaterials. 2014;35(5):1552-1561.
33. Kim IW, Lee JH, Kwon YN, Yun EY, Nam SH, Ahn MY, Kang DC and Hwang JS. Anticancer activity of a synthetic peptide derived from harmoniasin, an antibacterial peptide from the ladybug Harmonia axyridis. Int J Oncol. 2013;43(2):622-628.
34. Vad BS, Bertelsen K, Johansen CH, Pedersen JM, Skrydstrup T, Nielsen NC and Otzen DE. Pardaxin permeabilizes vesicles more efficiently by pore formation than by disruption. Biophys J. 2010;98(4):576-585.
35. Ramamoorthy A, Lee DK, Narasimhaswamy T and Nanga RP. Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR. Biochim Biophys Acta. 2010;1798(2):223-227.
36. Lu L, Shi W, Deshmukh RR, Long J, Cheng X, Ji W, Zeng G, Chen X, Zhang Y and Dou QP. Tumor Necrosis Factor-a Sensitizes Breast Cancer Cells to Natural Products with Proteasome-Inhibitory Activity Leading to Apoptosis. PLoS One. 2014;9(11):e113783.
37. Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS and Mandal C. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis. 2008;13(12):1450-1464.
38. Wang CY, Mayo MW and Baldwin AS Jr. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 1996;274(5288):784-787.
39. Castigli E, Arcuri C, Giovagnoli L, Luciani R, Giovagnoli L, Secca T, Gianfranceschi GL and Bocchini V. Interleukin-1beta induces apoptosis in GL15 glioblastoma-derived human cell line. Am J Physiol Cell Physiol. 2000;279(6):C2043-2049.
40. Park C, Yoo JH, Kim HJ, Lim CY, Kim JW, Lee SY, Kim JH, Jang JI and Park HM. Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog. Can Vet J. 2010;51(11):1279-1282.
41. Javanbakht J, Tavassoli A, Sasani F, Sabbagh A, Hassan MA, Samakkhah SA, Shafiee R, Jani M, Alimohammadi S, Samani R, Barati F and Ghalee VR. An overall assessment of circumanal gland adenoma in a terrier mix breed dog. Asian Pac J Trop Biomed. 2013;3(7):580-583.
42. Ryu JS and Raucher D. Anti-tumor efficacy of a therapeutic peptide based on thermo-responsive elastin-like polypeptide in combination with gemcitabine. Cancer Lett. 2014;348(1-2):177-184.